公开(公告)号：US20240294633A1

公开(公告)日：2024-09-05

申请号：US18566522

申请日：2022-06-06

Applicant: NONAGEN THERAPEUTICS CORPORATION

Inventor： Charles J. ROSSER ,  Hideki FURUYA

IPC: C07K16/28 ,  A61K39/00 ,  A61P35/00 ,  G01N33/543

CPC classification number: C07K16/28 ,  A61P35/00 ,  G01N33/543 ,  A61K2039/505 ,  C07K2317/24 ,  C07K2317/565 ,  C07K2317/567

Abstract: Antibodies against human B cell lymphoma 6 protein (BCL-6) are provided. The antibodies have neutralizing activity against BCL-6. The anti-human B cell lymphoma 6 protein antibodies may be used in therapeutic treatment in patients with angiogenesis-dependent conditions.